Bilirubin, a curse and a boon

Gut

Volumn 52, Issue 12, 2003, Pages 1668-1670

  Ostrow, J D ^a,c   Tiribelli, C ^b  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF TRIESTE   (Italy)

^c Research Service (151L)   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABC TRANSPORTER; BILE SALT; BILIRUBIN; BILIVERDIN; CYTOCHROME P450 1A1; CYTOCHROME P450 1A2; FATTY ACID BINDING PROTEIN; HEME OXYGENASE; LIGANDIN; MULTIDRUG RESISTANCE PROTEIN 1; MULTIDRUG RESISTANCE PROTEIN 3;

APOPTOSIS; ASTROCYTE; BILIRUBIN BINDING; BILIRUBIN BLOOD LEVEL; BILIRUBIN METABOLISM; BRAIN DISEASE; CELL DEATH; CHOLESTASIS; CONCENTRATION RESPONSE; CYTOTOXICITY; HUMAN; HYPERBILIRUBINEMIA; KERNICTERUS; LIVER CELL; LIVER MITOCHONDRION; MEMBRANE PERMEABILITY; MITOCHONDRIAL MEMBRANE; NERVE CELL CULTURE; NEWBORN JAUNDICE; NONHUMAN; NOTE; OXIDATION; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION;

ATP-BINDING CASSETTE TRANSPORTERS; BILIRUBIN; CARRIER PROTEINS; FATTY ACID-BINDING PROTEINS; HEPATOCYTES; HUMANS; HYPERBILIRUBINEMIA; OXIDATION-REDUCTION; TUMOR SUPPRESSOR PROTEINS;

EID: 0345096509     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.52.12.1668     Document Type: Note

References (55)

1. Botla R, Spivey JR, Aguilar H, et al. Ursodeoxycholate (UDCA) inhibits the mitochondrial membrane permeability transition induced by glycochenodeoxycholate: a mechanism of UDCA cytoprotection. J Pharmacol Exp Ther 1995;272:930-8.
2. Rodrigues CM, Fan G, Wong PY, et al. Ursodeoxycholic acid may inhibit deoxycholic acid-induced apoptosis by modulating mitochondrial transmembrane potential and reactive oxygen species production. Mol Med 1998;4:165-78.
3. Ostrow JD, Pascolo L, Tiribelli C. Reassessment of the unbound concentrations of unconjugated bilirubin in relation to neurotoxicity in vitro. Pediatr Res 2003;54:98-104.
4. Beuers U, Boyer JL, Paumgartner G. Ursodeoxycholic acid in cholestasis: potential mechanism for action and therapeutic applications. Hepatology 1998;28:1449-53.
5. Gourley GR. Bilirubin metabolism and kernicterus. Adv Pediatr 1997;44:173-229.
6. Rodrigues CMP, Sola S, Brites D. Bilirubin induces apoptosis via the mitochondrial pathway in developing rat brain neurons. Hepatology 2002;35:1186-95.
7. Silva RFM, Rodrigues CMP, Brites D. Bilirubin-induced apoptosis in cultured rat neural cells is aggravated by chenodeoxycholic acid but prevented by ursodeoxycholic acid. J Hepatol 2001;34:402-8.
8. Granato A, Gores G, Vilei MT, et al. Bilirubin inhibits bile acid induced apoptosis in rat hepatocytes. Gut 2003;52:1774-8.
9. Ostrow JD, Tiribelli C. Editorial: New concepts in bilirubin neurotoxicity and the need for studies at clinically relevant bilirubin concentrations. J Hepatol 2001;34:467-70.
10. Ostrow JD. In vitro studies of bile salt toxicity. Hepatology 1994;19:1538-9.
11. Hahm JS, Ostrow JD, Mukerjee P, et al. Ionization and self-association of unconjugated bilirubin, determined by rapid solvent partition from chloroform, with further studies of bilirubin solubility. J Lipid Res 1992;33:1123-37.
12. Brodersen R, Stern L. Aggregation of bilirubin in injectates and incubation media: its significance in experimental studies of CNS toxicity. Neuropediatrics 1987;18:34-6.
13. σ determinations. BMC Biochemistry 2002;3:17.
14. McDanagh AF, Assisi F. The ready isomerization of bilirubin-IXα in aqueous solution. Biochem J 1972;129:797-800.
15. Del Vecchio S, Ostrow JD, Mukerjee P, et al. Method for removal of surface-active impurities and calcium from conjugated bile salt preparations: comparison with silicic acid chromatography. J Lipid Res 1995;36:2639-50.
16. Hirsch JI, Ahrens EH Jr. The separation of complex lipid mixtures by the use of silicic acid chromatography. J Biol Chem 1958;233:311-20.
17. Stocker R, Yamamoto Y, McDonagh AF, et al. Bilirubin is an antioxidant of possible physiological importance. Science 1987;235:1043-6.
18. Stocker R, Peterhans E. Synergistic interaction between vitamin E and the bile pigments bilirubin and biliverdin. Biochim Biophys Acta 1989;1002:238-44.
19. Tomaro ML, Batlle AMD. Bilirubin: its role in cytoprotection against oxidative stress. Int J Biochem Cell Biol 2002;34:216-20.
20. Dore S, Snyder SH. Neuroprotective action of bilirubin against oxidative stress in primary hippocampal cultures. Ann N Y Acad Sci 1999;890:167-72.
21. Ostrow JD, Kapitulnik J. Alternate pathways of heme and bilirubin metabolism. In: Ostrow JD, ed. Bile pigments and jaundice: molecular, metabolic and medical aspects. New York: Marcel Dekker, 1986:421-38.
22. Stocker R, Glazer AN, Ames BN. Antioxidant activity of albumin-bound bilirubin. Proc Natl Acad Sci U S A 1987;84:5918-22.
23. Brass CA, Wrchota EM, Gollan JL. Bilirubin is a potent inhibitor of lipid peroxidation in hepatic microsomal membranes. Hepatology 1989;10:609.
24. Ahlfors CE. Bilirubin-albumin binding and free bilirubin. J Perinatol 2001;21(suppl 1):S40-2.
25. Weisiger RA, Ostrow JD, Koehler RK, et al. Affinity of human serum albumin for bilirubin varies with albumin concentration and buffer composition: results of a novel ultrafiltration method. J Biol Chem 2001;276:29953-60.
26. Zucker SD, Goessling W, Hoppin AG. Unconjugated bilirubin exhibits spontaneous diffusion through model lipid bilayers and native hepatocyte membranes. J Biol Chem 1999;274:10852-62.
27. Ryter SW, Tyrrell RM. The heme synthesis and degradation pathways: role in oxidant sensitivity. Heme oxygenase has both pro-and antioxidant properties. Free Radic Biol Med 2000;28:289-309.
28. Dore S, Takahashi M, Ferris CD, et al. Bilirubin, formed by activation of heme oxygenase-2, protects neurons against oxidative stress injury. Proc Natl Acad Sci U S A 1999;96:2445-50.
29. Clark JE, Foresti R, Green CJ, et al. Dynamics of haem oxygenase-1 expression and bilirubin production in cellular protection against oxidative stress. Biochem J 2000;348:615-19.
30. Zuckerbraun BS, Billiar TR. Heme oxygenase-1: a cellular Hercules. Hepatology 2003;37:742-4.
31. Barañano DE, Rao M, Ferris CD, et al. From the Cover: Biliverdin reductase: A major physiologic cytoprotectant. Proc Natl Acad Sci U S A 2002;99:16093-8.
32. Schenker S, McCandless DW, Wittgenstein E. Studies in vivo of the effect of unconjugated bilirubin on hepatic phosphorylation and respiration. Gut 1966;7:409-14.
33. Ghersi-Egea JF, Strazielle N. Brain drug delivery, drug metabolism, and multidrug resistance at the choroid plexus. Microsc Res Tech 2001;52:83-8.
34. Lieser MJ, Park J, Natori S, et al. Cholestasis confers resistance to the rat liver mitochondrial permeability transition. Gastroenterology 1998;115:693-701.
35. Borst P, Oude Elferink R. Mammalian abc transporters in health and disease. Annu Rev Biochem 2002;71:537-92.
36. Kullak-Ublick GA, Beuers U, Paumgartner G. Hepatobiliary transport. J Hepatol 2000;32(suppl 1):3-18.
37. Munoz ME, Esteller A, Gonzalez J. Substrate induction of bilirubin conjugation and biliary excretion in the rat. Clin Sci 1987;73:371-5.
38. Huang W, Zhang J, Chua SS, et al. Induction of bilirubin clearance by the constitutive androstane receptor (CAR). Proc Natl Acad Sci U S A 2003;100:4156-61.
39. Wijnholds J, de Lange EC, Scheffer GL, et al. Multidrug resistance protein 1 protects the choroid plexus epithelium and contributes to the blood-cerebrospinal fluid barrier. J Clin Invest 2000;105:279-85.
40. Watchko JF, Daood MJ, Hansen TWR. Brain bilirubin content is increased in P-glycoprotein-deficient transgenic null mutant mice. Pediatr Res 1998;44:763-6.
41. Watchko JF, Ziegler J, Daood MJ, et al. Inhibition of human MDR1 P-glycoprotein increases bilirubin-induced cell apoptosis in vitro. Pediatr Res 2003;53:400A.
42. Gosland MP, Brophy NA, Duran GE, et al. Bilirubin: a physiological substrate for the multidrug transporter. Proc Am Assn Cancer Res 1991;32:426.
43. Petrovic S, Pascolo L, Gallo R, et al. The products of YCF1 and YLL015w (BPT1) cooperate for the ATP-dependent vacuolar transport of unconjugated bilirubin in Saccharomyces cerevisiae. Yeast 2000;16:561-71.
44. Pascolo L, Fernetti C, Crivellato E, et al. Mechanisms for the transport of unconjugated bilirubin in human trophoblastic BeWo cells. FEBS Lett 2001;495:94-9.
45. Strassburg CP, Manns MP. Jaundice, genes and promoters. J Hepatol 2000;33:476-9.
46. Kapitulnik J, Gonzalez FJ. Marked endogenous activation of the CYP1A1 and CYP1A2 genes in the congenitally jaundiced Gunn rat. Mol Pharmacol 1993;43:722-5.
47. Jorritsma U, Schrader E, Klaunick G, et al. Monitoring of cytochrome P-450 1A activity by determination of the urinary pattern of caffeine metabolites in Wistar and hyperbilirubinemic Gunn rats. Toxicology 2000;144:229-36.
48. Phelan D, Winter GM, Rogers WJ, et al. Activation of the Ah receptor signal transduction pathway by bilirubin and biliverdin. Arch Biochem Biophys 1998;357:155-63.
49. Zucker SD, Gössling W, Ransil BJ, et al. Influence of glutathione S-transferase B (ligandin) on the intermembrane transfer of bilirubin- implications for the intracellular transport of nonsubstrate ligands in hepatocytes. J Clin Invest 1995;98:1927-35.
50. Takikawa H, Sugiyama Y, Kaplowitz N. Binding of bile acids by glutathione S-transferases from rat liver. J Lipid Res 1986;27:955-66.
51. Stolz A, Sugiyama Y, Kuhlenkamp J, et al. Cytosolic bile acid binding protein in rat liver: radioimmunoassay, molecular forms, developmental characteristics and organ distribution. Hepatology 1986;6:433-9.
52. Abramovitz M, Homma H, Ishigaki S, et al. Characterization and localization of glutathione-S-transferases in rat brain and binding of hormones, neurotransmitters, and drugs. J Neurochem 1988;50:50-7.
53. Sokol RJ, Devereaux M, Khandwala R, et al. Evidence for involvement of oxygen free radicals in bile acid toxicity to isolated rat hepatocytes. Hepatology 1993;17:869-81.
54. Mustafa MG, Cowger ML, King TE. Effects of bilirubin an mitochondrial reactions. J Biol Chem 1969;244:6403-14.
55. Menken M, Waggoner JG, Berlin NI. The influence of bilirubin on oxidative phosphorylation and related reactions in brain and liver mitochondria: effects of protein-binding. J Neurochem 1966;13:1241-8. 1670